The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease
Open accessAbstract
Diabetic cardiomyopathy is characterised in its early stages by diastolic relaxation abnormalities and later by clinical heart failure in the absence of dyslipidaemia, hypertension and coronary artery disease. Insulin resistance, hyperinsulinaemia and hyperglycaemia are each independent risk factors for the development of diabetic cardiomyopathy. The pathophysiological factors in diabetes that drive the development of cardiomyopathy include systemic metabolic disorders, inappropriate activation of the renin–angiotensin–aldosterone system, subcellular component abnormalities, oxidative stress, inflammation and dysfunctional immune modulation. These abnormalities collectively promote cardiac tissue interstitial fibrosis, cardiac stiffness/diastolic dysfunction and, later, systolic dysfunction, precipitating the syndrome of clinical heart failure. Recent evidence has revealed that dysregulation of coronary endothelial cells and exosomes also contributes to the pathology behind diabetic cardiomyopathy. Herein, we review the relationships among insulin resistance/hyperinsulinaemia, hyperglycaemia and the development of cardiac dysfunction. We summarise the current understanding of the pathophysiological mechanisms in diabetic cardiomyopathy and explore potential preventative and therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ma, H., Li, S., Xu, P., Babcock, S. A., Dolence, E. K., Brownlee, M., Li, J., & Ren, J. T. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00547.x · Cited by 169
RetractedEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · cited 1×
“Conversely, in a prospective observational study, each 1% reduction in HbA1c level was associated with a 16% reduction in risk for heart failure, 14% reduction in risk for myocardial infarction and 21% reduction in risk for deaths related to type 2 diabetes [13].”
BackgroundA Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564 · cited 1×
“Coronary endothelial dysfunction and dysregulation of exosomes The notion that dysfunctional coronary endothelial cells drive abnormal cardiac function has recently gained momentum [36, 37] (Figs 1, 2).”
BackgroundRole of diabetes in congestive heart failure: The Framingham study
Kannel, W. B., Hjortland, M., & Castelli, W. P. (1974) · The American Journal of Cardiology · doi:10.1016/0002-9149(74)90089-7 · Cited by 2,090
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,837
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
Jia, G., DeMarco, V. G., & Sowers, J. R. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.216 · Cited by 949
Self-citationEndoplasmic Reticulum Stress Signaling in Disease
Marciniak, S. J., & Ron, D. (2006) · Physiological Reviews · doi:10.1152/physrev.00015.2006 · Cited by 945
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Fang, Z. Y., Prins, J. B., & Marwick, T. H. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0012 · Cited by 912
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 879
The Incidence of Congestive Heart Failure in Type 2 Diabetes
Nichols, G. A., Gullion, C. M., Koro, C. E., Ephross, S. A., & Brown, J. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1879 · Cited by 812 · cited 1×
“5-fold increase in heart failure risk in those with type 2 diabetes [11].”
BackgroundThe cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovacs, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214080 · Cited by 763
Evidence for Cardiomyopathy in Familial Diabetes Mellitus
Regan, T. J., Lyons, M. M., Ahmed, S. S., Levinson, G. E., Oldewurtel, H. A., Ahmad, M. R., & Haider, B. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108843 · Cited by 728
van Heerebeek, L., Hamdani, N., Handoko, M. L., Falcao-Pires, I., Musters, R. J., Kupreishvili, K., Ijsselmuiden, A. J. J., Schalkwijk, C. G., Bronzwaer, J. G. F., Diamant, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.728550 · Cited by 723
Glycemic Control and Heart Failure Among Adult Patients With Diabetes
Iribarren, C., Karter, A. J., Go, A. S., Ferrara, A., Liu, J. Y., Sidney, S., & Selby, J. V. (2001) · Circulation · doi:10.1161/01.cir.103.22.2668 · Cited by 710
Sokos, G. G., Nikolaidis, L. A., Mankad, S., Elahi, D., & Shannon, R. P. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.08.211 · Cited by 656
de Jong, O. G., Verhaar, M. C., Chen, Y., Vader, P., Gremmels, H., Posthuma, G., Schiffelers, R. M., Gucek, M., & van Balkom, B. W. M. (2012) · Journal of Extracellular Vesicles · doi:10.3402/jev.v1i0.18396 · Cited by 634
Franssen, C., Chen, S., Unger, A., Korkmaz, H. I., De Keulenaer, G. W., Tschöpe, C., Leite-Moreira, A. F., Musters, R., Niessen, H. W. M., Linke, W. A., et al. (2016) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.10.007 · Cited by 597
Mudaliar, S., Alloju, S., & Henry, R. R. (2016) · Diabetes Care · doi:10.2337/dc16-0542 · Cited by 571 · cited 2×
“This notion has been confirmed in a study in which empagliflozin, a sodium–glucose cotransporter 2 (SGLT2) antagonist, elevated the ketone body levels in individuals with diabetes and heart failure [27].”
BackgroundXie, Z., Lau, K., Eby, B., Lozano, P., He, C., Pennington, B., Li, H., Rathi, S., Dong, Y., Tian, R., et al. (2011) · Diabetes · doi:10.2337/db10-0351 · Cited by 490 · cited 1×
“Impairment of normal autophagy, including defects in autophagosome and lysosome fusion in cardiomyocytes, is also involved in both diastolic and systolic cardiac dysfunction in diabetic cardiomyopathy [31].”
BackgroundVincent, M. A., Clerk, L. H., Lindner, J. R., Klibanov, A. L., Clark, M. G., Rattigan, S., & Barrett, E. J. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1418 · Cited by 438
NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
Luo, B., Li, B., Wang, W., Liu, X., Xia, Y., Zhang, C., Zhang, M., Zhang, Y., & An, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104771 · Cited by 408
Lind, M., Bounias, I., Olsson, M., Gudbjörnsdottir, S., Svensson, A.-M., & Rosengren, A. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60471-6 · Cited by 292
Raev, D. C. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.633 · Cited by 264
Udell, J. A., Cavender, M. A., Bhatt, D. L., Chatterjee, S., Farkouh, M. E., & Scirica, B. M. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00044-3 · Cited by 254
Wang, X., Gu, H., Huang, W., Peng, J., Li, Y., Yang, L., Qin, D., Essandoh, K., Wang, Y., Peng, T., et al. (2016) · Diabetes · doi:10.2337/db15-1563 · Cited by 239
Hu, Y., Belke, D., Suarez, J., Swanson, E., Clark, R., Hoshijima, M., & Dillmann, W. H. (2005) · Circulation Research · doi:10.1161/01.res.0000165478.06813.58 · Cited by 228
Liu, Z.-W., Zhu, H.-T., Chen, K.-L., Dong, X., Wei, J., Qiu, C., & Xue, J.-H. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-158 · Cited by 209
Impact of Hyperglycemia on the Renin Angiotensin System in Early Human Type 1 Diabetes Mellitus
MILLER, J. A. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1081778 · Cited by 185
Garcia, N. A., Moncayo-Arlandi, J., Sepulveda, P., & Diez-Juan, A. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvv260 · Cited by 185
Causes and Characteristics of Diabetic Cardiomyopathy
Wang, J., Song, Y., Wang, Q., Kralik, P. M., & Epstein, P. N. (2006) · The Review of Diabetic Studies · doi:10.1900/rds.2006.3.108 · Cited by 162
Jia, G., Habibi, J., DeMarco, V. G., Martinez‐Lemus, L. A., Ma, L., Whaley‐Connell, A. T., Aroor, A. R., Domeier, T. L., Zhu, Y., Meininger, G. A., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06015 · Cited by 145
Self-citationKim, J., Jang, H.-J., Martinez‐Lemus, L. A., & Sowers, J. R. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00497.2011 · Cited by 129
Self-citationHartog, J. W. L., Willemsen, S., van Veldhuisen, D. J., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr067 · Cited by 124
PPARs modulate cardiac metabolism and mitochondrial function in diabetes
Lee, T., Bai, K., Lee, T.-I., Chao, T., Kao, Y., & Chen, Y. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-016-0309-5 · Cited by 124
New Molecular Insights of Insulin in Diabetic Cardiomyopathy
Westermeier, F., Riquelme, J. A., Pávez, M., Garrido, V., Díaz, A., Verdejo, H., Castro, P., García, L., & Lavandero, S. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00125 · Cited by 121
Structural changes in the myocardium during diabetes-induced cardiomyopathy
Adeghate, E. A., & Singh, J. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9388-5 · Cited by 112
Atkinson, L. L., Kozak, R., Kelly, S. E., Onay-Beşikçi, A., Russell, J. C., & Lopaschuk, G. D. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00360.2002 · Cited by 111
Miller, J., Floras, J. S., Zinman, B., Skorecki, K. L., & Logan, A. G. (1996) · Clinical Science · doi:10.1042/cs0900189 · Cited by 100
Radovits, T., Korkmaz, S., Loganathan, S., Barnucz, E., Bömicke, T., Arif, R., Karck, M., & Szabo, G. B. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00165.2009 · Cited by 98
Shapiro, B. P., Owan, T., Mohammed, S. F., Meyer, D., Mills, L. D., Schalkwijk, C. G., & Redfield, M. M. (2008) · Circulation · doi:10.1161/circulationaha.108.777326 · Cited by 66
O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice
Makino, A., Dai, A., Han, Y., Youssef, K. D., Wang, W., Donthamsetty, R., Scott, B. T., Wang, H., & DILLMANN, W. H. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00069.2015 · Cited by 64
Brunvand, L. I., Fugelseth, D., Stensæth, K. H., Dahl‐Jørgensen, K., & Margeirsdottir, H. D. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0288-1 · Cited by 56
Diabetic myocardial disease: pathophysiology, early diagnosis and therapeutic options
Mytas, D. Z., Stougiannos, P. N., Zairis, M. N., Foussas, S. G., Pyrgakis, V. N., & Kyriazis, I. A. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2007.12.005 · Cited by 54
Corticosteroids, Heart Failure, and Hypertension: A Role for Immune Cells?
Shen, J., & Young, M. J. (2012) · Endocrinology · doi:10.1210/en.2012-1780 · Cited by 45
Lazo, M., Halushka, M. K., Shen, L., Maruthur, N. M., Rebholz, C. M., Rawlings, A. M., Hoogeveen, R. C., Brinkley, T. E., Ballantyne, C. M., Astor, B. C., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.08.008 · Cited by 43
Šuran, D., Sinkovič, A., & Naji, F. H. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0242-2 · Cited by 37
Integration of Apoptosis and Metabolism
Yi, C., Vakifahmetoglu-Norberg, H., & Yuan, J. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010777 · Cited by 20
Cited by
Tan, Y., Zhang, Z., Zheng, C., Wintergerst, K. A., Keller, B. B., & Cai, L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0339-2 · Cited by 835
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
The crucial role and mechanism of insulin resistance in metabolic disease
Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1149239 · Cited by 557
Mouton, A. J., Li, X., Hall, M. E., & Hall, J. E. (2020) · Circulation Research · doi:10.1161/circresaha.119.312321 · Cited by 546
Role of Insulin in Health and Disease: An Update
Rahman, M. S., Hossain, K. S., Das, S., Kundu, S., Adegoke, E. O., Rahman, M. A., Hannan, M. A., Uddin, M. J., & Pang, M.-G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126403 · Cited by 472
Metadata
- Authors
- Jia, G., Whaley-Connell, A., & Sowers, J. R.
- Venue
- Diabetologia
- Published
- 2017-08-03
- Volume
- 61
- Issue
- 1
- Pages
- 21-28
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2742824716
- Cited by
- 868
- References
- 48
- FWCI
- 29.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.